Cervical Cancer Awareness Month
With this first issue of 2021, you may notice something different on the cover and on the banner of our website. This special design features a teal ribbon wrap and related content for cervical cancer content.
As women’s health care providers, you likely know that January is Cervical Cancer Awareness month. The teal ribbon is its awareness symbol. To complement the print issue, key elements on our website will turn teal for the entire month of January and we will have related articles and interviews on the topic of cervical cancer. This is a first for us and we would like to hear your feedback on it.
Under the astute guidance of Editor-in-Chief Catherine Y. Spong, MD, we also are launching a new feature in this issue called Curbside Consults that engages practitioners outside of ob/gyn with expertise in health issues that may affect pregnant women. Take a dive into dental issues in pregnancy with 'Dental dilemmas in pregnancy.'
The other features in this issue focus on obstetrics, from the cover story on one method to address recurrent pregnancy loss by Nisse Clark, MD, MPH, to the article on diagnosis and management of syphilis in pregnancy by Emily Adhikari, MD, who reminds us that there are other infectious pathogens affecting our patients as we all work to get to the end of the COVID-19 pandemic.
We encourage your feedback. Please connect with us at COGeditorial@mmhgroup.com. Best wishes for a safe, healthy, and happy new year.
__
Mike Hennessy Sr.
Chairman and Founder, MJH Life Sciences
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
